• Email Us: [email protected]
  • Contact Us: +1 718 874 1545
  • Skip to main content
  • Skip to primary sidebar

Medical Market Report

  • Home
  • All Reports
  • About Us
  • Contact Us

New Oral Compound Could Prevent And Treat Osteoporosis

December 8, 2022 by Deborah Bloomfield

A new oral drug compound may be able to stimulate the body to form bone and increase bone mass, possibly preventing and treating osteoporosis in patients, according to a study in mice. The discovery may offer an alternative to the current hormone treatments, which can only be given by daily injection, and could result in better usability and reduced costs.  

The compound is based on the parathyroid hormone signaling pathway, which has shown success in stimulating bone growth in previous drugs. 

Advertisement

“Currently there are no orally available medications for osteoporosis that stimulate bone formation. We sought to develop such medications based upon our detailed understanding of the pathways that normally govern bone production,” said senior author Marc Wein in a statement. 

Osteoporosis is a disease that gradually weakens bones and leaves them liable to easy breakages. It is typically diagnosed after breaking a wrist or a hip, but the progression can leave bones so vulnerable that ribs can break after just a sneeze. It is typically treated with medicine to reinforce the affected bones, by stimulating the body to generate bone tissue or helping to maintain bone density. 

To investigate a drug candidate that could form an oral osteoporosis treatment, researchers from Massachusetts General Hospital (MGH) delved into the parathyroid hormone signaling pathway, which involves two enzymes that inhibit bone growth and remodeling. The aim of the drug is to inhibit these enzymes, called SIK2 and SIK3, to increase bone mass. 

Advertisement

The researchers created a detailed model of these enzymes and used it to identify a drug candidate that inhibits both. Using genetically-modified mice, the researchers then delivered an oral form of the drug – called SK-124 – to see whether it can mimic the success they previously had when directly delivering it to cells. The results showed an increase in blood calcium and vitamin D levels, and boosted bone development in the mice that received the drug, while no toxicity was recorded in the short term. 

Now, the team wants to move fast in bringing the drug to human clinical trials. 

“Based on these findings, we propose that small molecules like SK-124 might represent ‘next generation’ oral bone building therapies for osteoporosis,” said Wein.

Advertisement

“We are currently collaborating with a pharmaceutical company – Radius Health, Inc. – to further optimize and develop this compound into a treatment for patients.” 

The study was published in PNAS.

Deborah Bloomfield
Deborah Bloomfield

Related posts:

  1. Capital One CEO settles charges of repeatedly breaking U.S. antitrust laws -FTC
  2. Most executives think their ESG programs fall short, survey finds
  3. Air New Zealand to require COVID-19 vaccination for international travelers
  4. How Science Helped Catch The Golden State Killer

Source Link: New Oral Compound Could Prevent And Treat Osteoporosis

Filed Under: News

Primary Sidebar

  • If Birds Are Dinosaurs, Why Are None As Big As T. Rexes?
  • Psychologists Demonstrate Illusion That Could Be Screwing Up Our Perception Of Time
  • Why Are So Many Enormous Roman Shoes Being Discovered At Hadrian’s Wall?
  • Scientists Think They’ve Pinpointed Structural Differences In Psychopaths’ Brains
  • We’ve Found Our Third-Ever Interstellar Visitor, Orcas Filmed Kissing (With Tongues) In The Wild, And Much More This Week
  • The “Eyes Of Clavius” Will Be Visible On The Moon Today, Thanks To Clair-Obscur Effect
  • Shockingly High Microplastic Levels Found On Remote Mediterranean Coral Reef Island
  • Interstellar Object, Cheesy Nightmares, And Smooching Orcas
  • World’s Largest Martian Meteorite Up For Auction Could Reach Whopping $2-4 Million
  • Kimalu The Beluga Whale Undergoes Pioneering Surgery And Becomes First Beluga To Survive General Aesthetic
  • The 1986 Soviet Space Mission That’s Never Been Repeated: Mir To Salyut And Back Again
  • Grisly Incident In Yellowstone National Park Shows Just How Dangerous This Vibrant Wilderness Can Be
  • Out Of All Greenhouse Gas Emitters On Earth, One US Organization Takes The Biscuit
  • Overly Ambitious Adder Attempts To Eat Hare 10 Times Its Mass In Gnarly Video
  • How Fast Does A Spacecraft Need To Go To Escape The Solar System?
  • President Trump’s Cuts To USAID Could Result In A “Staggering” 14 Million Avoidable Deaths By 2030
  • Dzo: Hybrids Beasts That Are Perfectly Crafted For Life On Earth’s Highest Mountains
  • “Rarest Event Ever” Had A Half-Life 1 Trillion Times Longer Than The Age Of The Universe – How Did We See It?
  • Meet The Bille, A Self-Righting Tetrahedron That Nobody Was Sure Could Exist
  • Neurogenesis Confirmed: Adult Brains Really Do Make New Hippocampal Neurons
  • Business
  • Health
  • News
  • Science
  • Technology
  • +1 718 874 1545
  • +91 78878 22626
  • [email protected]
Office Address
Prudour Pvt. Ltd. 420 Lexington Avenue Suite 300 New York City, NY 10170.

Powered by Prudour Network

Copyrights © 2025 · Medical Market Report. All Rights Reserved.

Go to mobile version